The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 26, 2024

Filed:

Nov. 16, 2018
Applicants:

Centre National DE LA Recherche Scientifique, Paris, FR;

Universite Paris-saclay, Saint-Aubin, FR;

Inventors:

Nicolas Tsapis, Paris, FR;

Julien Nicolas, Igny, FR;

Tanguy Boissenot, Paris, FR;

Alexandre Bordat, Paris, FR;

Assignees:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 9/00 (2006.01); A61K 47/58 (2017.01); A61K 49/00 (2006.01); C08F 220/56 (2006.01); C08F 293/00 (2006.01);
U.S. Cl.
CPC ...
A61K 47/58 (2017.08); A61K 9/0019 (2013.01); A61K 49/0041 (2013.01); A61K 49/0054 (2013.01); C08F 220/56 (2013.01); C08F 293/005 (2013.01); C08F 2438/03 (2013.01);
Abstract

The invention relates to new prodrugs of active molecules. These prodrugs allow, in particular, the subcutaneous or intramuscular administration of active molecules of which the subcutaneous or intramuscular administration is problematic or impossible, in particular because of the toxicity at the injection site. The prodrugs according to the invention comprise an active ingredient, covalently linked with a polymer chain, preferably a hydrophilic and/or thermosensitive polymer chain. The invention relates, in particular, to polymeric prodrugs comprising a polymer chain formed at least in part by acrylamide monomer or one of its derivatives, said polymer comprising a proximal part and a terminal part; a first pharmaceutically active molecule covalently coupled to the proximal part of the polymer; possibly a second pharmaceutically active molecule covalently coupled to the terminal part of the polymer.


Find Patent Forward Citations

Loading…